0      0

2020 ISPE Biopharmaceutical Manufacturing Virtual Conference


Innovation in Technological Platforms in Biopharmaceutical Manufacturing


Jun 2, 2020 2:30pm ‐ Jun 2, 2020 3:30pm

Description

As described in the morning session, regulatory expectations continue to evolve given the complexities associated with new products and innovation. This session will provide an opportunity to hear more about this topic in the context of an innovative vaccine facility and related sterile manufacturing requirements.

Moderator(s):

  • Stephen Mahoney, JD, Senior Director, Global Quality & Compliance, Genentech, A Member of the Roche Group

Speaker(s):

  • Maria Hoffman, Executive Director, Supply Chain Management, Merck & Co., Inc.
  • Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment, CDER/FDA

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content